Clinical Trials Directory

Trials / Withdrawn

WithdrawnNCT02649010

A Performance Evaluation of the Enlite 3 Sensor

Status
Withdrawn
Phase
N/A
Study type
Interventional
Enrollment
0 (actual)
Sponsor
Medtronic MiniMed, Inc. · Industry
Sex
All
Age
14 Years – 75 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to support the use of the Enlite 3 sensor in arm and thigh in subjects age 14 - 75 years and provide additional characterization of the Enlite 3 sensor performance in arm in subjects age 14 - 75 years.

Detailed description

The study is a multi-center, randomized, prospective single-sample correlational design without controls.

Conditions

Interventions

TypeNameDescription
DEVICEEnlite 3 SensorUse of Enlite 3 Sensor over 168 hours (7 days) when inserted in the arm and used with the 640G Pump in subjects aged 14-75 years who have had a diagnosis of type 1 or type 2 diabetes for at least 12 months.

Timeline

Start date
2016-01-01
Primary completion
2016-05-01
Completion
2016-05-01
First posted
2016-01-07
Last updated
2016-06-23

Locations

2 sites across 1 country: United States

Source: ClinicalTrials.gov record NCT02649010. Inclusion in this directory is not an endorsement.